| 摘要 |
<p>Disclosed is a process for preparing of optical pure milnacipran and its pharmaceutically accepted salts, wherein racemic milnacipran is used as raw material and the resolution is carried out with tartaric acid derivatives or their compositions as resolving agents.</p> |
